C Gorman1, A Bhatia, A Rahman. Show Affiliations » 1. Centre for Rheumatology, Department of Medicine, University College of London, London, UK. clgorman@btopenworld.com
Abstract
Entities: Chemical Disease
Mesh: See more » Cyclophosphamide/administration & dosageCyclophosphamide/adverse effectsHumansImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/adverse effectsInjections, IntravenousLupus Nephritis/drug therapyPulse Therapy, DrugTreatment Outcome
Substances: See more » Immunosuppressive AgentsCyclophosphamide
Year: 2004 PMID: 15494351 DOI: 10.1093/rheumatology/keh440
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580